SlideShare a Scribd company logo
1 of 9
Global action plan to combat 
antimicrobial resistance 
Global action plan to combat 1 | antimicrobial resistance | 17 September 2014
Antimicrobial resistance (AMR) 
 Increasingly serious global public health threat 
 Winning the battle in some areas 
– Reduced AMR in some countries 
– Attention on infection control, use of medicines 
– Supported by increasing engagement with agriculture 
– Some increase in investment 
 But losing the war 
– AMR everywhere and increasing 
– Major knowledge gaps 
– Fragmented response 
Global action plan to combat 2 | antimicrobial resistance | 17 September 2014
World Health Assembly resolution on AMR 
 Resolution WHA67.25 requests the Director-General “to develop a draft 
global action plan to combat antimicrobial resistance ... 
to ensure that all countries ... have the capacity to 
combat antimicrobial resistance”. 
– Take account of existing action plans and 
all available evidence and best practice 
– Apply a multisectoral approach through consultation 
 Planned to be submitted to 2015 Health Assembly 
through the Executive Board (January 2015) 
Global action plan to combat 3 | antimicrobial resistance | 17 September 2014
Draft global action plan 
 Includes: 
– context, including current progress 
– main concerns or priorities for action 
– guiding principles and values 
– key targets and quantifiable objectives 
– monitoring and reporting of progress 
– key stakeholders (roles and responsibilities) 
– support functions and mechanisms (including WHO role). 
Global action plan to combat 4 | antimicrobial resistance | 17 September 2014
Draft global action plan 
 Based on 6 guiding principles 
– Whole-of-society engagement 
– Actions based on best available knowledge and evidence 
– Prevention first 
– Access, not excess 
– Sustainability 
– Incremental targets for implementation 
Global action plan to combat 5 | antimicrobial resistance | 17 September 2014
Five strategic objectives 
 Improve awareness and understanding 
 Strengthen the knowledge and evidence base 
 Reduce the incidence of infection 
 Optimize the use of antimicrobial medicines 
 Develop the business case for sustainable investment 
Commitments to report on progress and monitor impact 
Global action plan to combat 6 | antimicrobial resistance | 17 September 2014
Consultation and 
multisectoral engagement 
 Regional committee sessions 
 Consultation with Member States, 16 October 2014, Geneva 
 Consultations led by Member States 
– Netherlands, June 2014 – One Health 
– Brazil, October 2014 – research and knowledge gaps 
– Norway (7 sponsor countries), November 2014 – optimizing use 
– Sweden, December 2014 – establishing global surveillance for AMR 
Global action plan to combat 7 | antimicrobial resistance | 17 September 2014
Consultation and 
multisectoral engagement 
 Meetings of WHO’s Strategic and Technical Advisory Group on Antimicrobial 
Resistance (STAG) 
– September 2013, April 2014, October 2014 
 Bilateral and multilateral engagement 
– World Bank, Food and Agriculture Organization of the United Nations (FAO), 
World Organisation for Animal Health (OIE) and others to address 
the economic impact 
 A web-based consultation for input in draft action plan 
– July–August 2014 
– 2nd web call, January 2015 
Global action plan to combat 8 | antimicrobial resistance | 17 September 2014
Thank you

More Related Content

What's hot

Global consultation on environmentally friendly procurement in the health sector
Global consultation on environmentally friendly procurement in the health sectorGlobal consultation on environmentally friendly procurement in the health sector
Global consultation on environmentally friendly procurement in the health sectorUNDP Eurasia
 
Presentation – Action plan for the health sector response to viral hepatitis
Presentation – Action plan for the health sector response to viral hepatitis Presentation – Action plan for the health sector response to viral hepatitis
Presentation – Action plan for the health sector response to viral hepatitis WHO Regional Office for Europe
 
Michael Craig - Updates from the CDC
Michael Craig - Updates from the CDCMichael Craig - Updates from the CDC
Michael Craig - Updates from the CDCJohn Blue
 
Antibiotic Guardian Birmingham Workshop
Antibiotic Guardian Birmingham WorkshopAntibiotic Guardian Birmingham Workshop
Antibiotic Guardian Birmingham Workshop4 All of Us
 
Accelerating implementation of the International Health Regulations (2005) an...
Accelerating implementation of the International Health Regulations (2005) an...Accelerating implementation of the International Health Regulations (2005) an...
Accelerating implementation of the International Health Regulations (2005) an...WHO Regional Office for Europe
 
The role of Sustainable Procurement in the Health Sector in global health ini...
The role of Sustainable Procurement in the Health Sector in global health ini...The role of Sustainable Procurement in the Health Sector in global health ini...
The role of Sustainable Procurement in the Health Sector in global health ini...UN SPHS
 
Benefits case study summary – prescriptions dispensed in the community’ publi...
Benefits case study summary – prescriptions dispensed in the community’ publi...Benefits case study summary – prescriptions dispensed in the community’ publi...
Benefits case study summary – prescriptions dispensed in the community’ publi...The Health and Social Care Information Centre
 
Sustainable Development and Global Health Aid - a UNDP Perspective
Sustainable Development and Global Health Aid - a UNDP PerspectiveSustainable Development and Global Health Aid - a UNDP Perspective
Sustainable Development and Global Health Aid - a UNDP PerspectiveUNDP Eurasia
 
Healthcare Waste Management in the Context of Global Health Initiatives
Healthcare Waste Management in the Context of Global Health InitiativesHealthcare Waste Management in the Context of Global Health Initiatives
Healthcare Waste Management in the Context of Global Health InitiativesUNDP Eurasia
 
Alf Nicholson, National Clinical lead in Pediatrics, RCPI
Alf Nicholson, National Clinical lead in Pediatrics, RCPIAlf Nicholson, National Clinical lead in Pediatrics, RCPI
Alf Nicholson, National Clinical lead in Pediatrics, RCPIInvestnet
 
The Global Burden of Antimicrobial Resistance
The Global Burden of Antimicrobial ResistanceThe Global Burden of Antimicrobial Resistance
The Global Burden of Antimicrobial ResistanceMassimo Sartelli
 

What's hot (20)

Benefits case study summary: Diabetes Uk Putting Feet First Campaign
Benefits case study summary: Diabetes Uk Putting Feet First CampaignBenefits case study summary: Diabetes Uk Putting Feet First Campaign
Benefits case study summary: Diabetes Uk Putting Feet First Campaign
 
Global consultation on environmentally friendly procurement in the health sector
Global consultation on environmentally friendly procurement in the health sectorGlobal consultation on environmentally friendly procurement in the health sector
Global consultation on environmentally friendly procurement in the health sector
 
Presentation – Action plan for the health sector response to viral hepatitis
Presentation – Action plan for the health sector response to viral hepatitis Presentation – Action plan for the health sector response to viral hepatitis
Presentation – Action plan for the health sector response to viral hepatitis
 
Michael Craig - Updates from the CDC
Michael Craig - Updates from the CDCMichael Craig - Updates from the CDC
Michael Craig - Updates from the CDC
 
Benefits case study summary: NHS Immunisation Statistics Publication
Benefits case study summary: NHS Immunisation Statistics PublicationBenefits case study summary: NHS Immunisation Statistics Publication
Benefits case study summary: NHS Immunisation Statistics Publication
 
WHO/Europe priorities and activities. Danilo Lo Fo Wong (WHO/Europe)
WHO/Europe priorities and activities. Danilo Lo Fo Wong (WHO/Europe)WHO/Europe priorities and activities. Danilo Lo Fo Wong (WHO/Europe)
WHO/Europe priorities and activities. Danilo Lo Fo Wong (WHO/Europe)
 
Antibiotic Guardian Birmingham Workshop
Antibiotic Guardian Birmingham WorkshopAntibiotic Guardian Birmingham Workshop
Antibiotic Guardian Birmingham Workshop
 
Accelerating implementation of the International Health Regulations (2005) an...
Accelerating implementation of the International Health Regulations (2005) an...Accelerating implementation of the International Health Regulations (2005) an...
Accelerating implementation of the International Health Regulations (2005) an...
 
The role of Sustainable Procurement in the Health Sector in global health ini...
The role of Sustainable Procurement in the Health Sector in global health ini...The role of Sustainable Procurement in the Health Sector in global health ini...
The role of Sustainable Procurement in the Health Sector in global health ini...
 
Benefits case study summary – prescriptions dispensed in the community’ publi...
Benefits case study summary – prescriptions dispensed in the community’ publi...Benefits case study summary – prescriptions dispensed in the community’ publi...
Benefits case study summary – prescriptions dispensed in the community’ publi...
 
Sustainable Development and Global Health Aid - a UNDP Perspective
Sustainable Development and Global Health Aid - a UNDP PerspectiveSustainable Development and Global Health Aid - a UNDP Perspective
Sustainable Development and Global Health Aid - a UNDP Perspective
 
Benefits case study: NHS Immunisation Statistics Publication
Benefits case study: NHS Immunisation Statistics PublicationBenefits case study: NHS Immunisation Statistics Publication
Benefits case study: NHS Immunisation Statistics Publication
 
Phytothreats: DEFRA
Phytothreats: DEFRAPhytothreats: DEFRA
Phytothreats: DEFRA
 
Healthcare Waste Management in the Context of Global Health Initiatives
Healthcare Waste Management in the Context of Global Health InitiativesHealthcare Waste Management in the Context of Global Health Initiatives
Healthcare Waste Management in the Context of Global Health Initiatives
 
Alf Nicholson, National Clinical lead in Pediatrics, RCPI
Alf Nicholson, National Clinical lead in Pediatrics, RCPIAlf Nicholson, National Clinical lead in Pediatrics, RCPI
Alf Nicholson, National Clinical lead in Pediatrics, RCPI
 
Child Health
Child HealthChild Health
Child Health
 
European Commission support actions for laboratory preparedness
European Commission support actions for laboratory preparednessEuropean Commission support actions for laboratory preparedness
European Commission support actions for laboratory preparedness
 
The Global Burden of Antimicrobial Resistance
The Global Burden of Antimicrobial ResistanceThe Global Burden of Antimicrobial Resistance
The Global Burden of Antimicrobial Resistance
 
Stenberg - Child Health
Stenberg - Child HealthStenberg - Child Health
Stenberg - Child Health
 
Strategic issues on WHO agenda
Strategic issues on WHO agendaStrategic issues on WHO agenda
Strategic issues on WHO agenda
 

Viewers also liked

2010 mazda mx 5 miata grand touringw power retractable hard top for sale | me...
2010 mazda mx 5 miata grand touringw power retractable hard top for sale | me...2010 mazda mx 5 miata grand touringw power retractable hard top for sale | me...
2010 mazda mx 5 miata grand touringw power retractable hard top for sale | me...Ralph Paglia
 
9 131002231342-phpapp02
9 131002231342-phpapp029 131002231342-phpapp02
9 131002231342-phpapp02Sompron052
 
feras zegan c.v 29.06.2016
feras zegan c.v 29.06.2016feras zegan c.v 29.06.2016
feras zegan c.v 29.06.2016Firas Zighan
 
ali's test
ali's test ali's test
ali's test Aliw88
 
Demandware Shopping Index | 2015 Q1
Demandware Shopping Index | 2015 Q1Demandware Shopping Index | 2015 Q1
Demandware Shopping Index | 2015 Q1Demandware
 
Benefits of Image Optimization | B Line Marketing
Benefits of Image Optimization | B Line MarketingBenefits of Image Optimization | B Line Marketing
Benefits of Image Optimization | B Line MarketingB Line Marketing
 
Présentation - AtHome
Présentation - AtHomePrésentation - AtHome
Présentation - AtHomeRamsi Ferkous
 
HAPPYWEEK 202 - 2017.01.16.
HAPPYWEEK 202 - 2017.01.16.HAPPYWEEK 202 - 2017.01.16.
HAPPYWEEK 202 - 2017.01.16.Jiří Černák
 
Expertise: Retail | Kids | Toys | Pets
Expertise: Retail | Kids | Toys | PetsExpertise: Retail | Kids | Toys | Pets
Expertise: Retail | Kids | Toys | PetsCory Earl
 
L2 Intelligence Report: E-Commerce Agility
L2 Intelligence Report: E-Commerce AgilityL2 Intelligence Report: E-Commerce Agility
L2 Intelligence Report: E-Commerce AgilityDemandware
 
HAPPYWEEK 203 - 2017.01.23.
HAPPYWEEK 203 - 2017.01.23.HAPPYWEEK 203 - 2017.01.23.
HAPPYWEEK 203 - 2017.01.23.Jiří Černák
 
Roberto veiga unir complementos-t03 entregable stem 20160621
Roberto veiga   unir complementos-t03 entregable stem 20160621Roberto veiga   unir complementos-t03 entregable stem 20160621
Roberto veiga unir complementos-t03 entregable stem 20160621RVeiga UNIR Máster Secundaria
 

Viewers also liked (20)

2010 mazda mx 5 miata grand touringw power retractable hard top for sale | me...
2010 mazda mx 5 miata grand touringw power retractable hard top for sale | me...2010 mazda mx 5 miata grand touringw power retractable hard top for sale | me...
2010 mazda mx 5 miata grand touringw power retractable hard top for sale | me...
 
8д8д
 
9 131002231342-phpapp02
9 131002231342-phpapp029 131002231342-phpapp02
9 131002231342-phpapp02
 
omar c.v.
omar c.v.omar c.v.
omar c.v.
 
Guided writing
Guided writingGuided writing
Guided writing
 
feras zegan c.v 29.06.2016
feras zegan c.v 29.06.2016feras zegan c.v 29.06.2016
feras zegan c.v 29.06.2016
 
ali's test
ali's test ali's test
ali's test
 
Demandware Shopping Index | 2015 Q1
Demandware Shopping Index | 2015 Q1Demandware Shopping Index | 2015 Q1
Demandware Shopping Index | 2015 Q1
 
9а9а
 
9б9б
 
Benefits of Image Optimization | B Line Marketing
Benefits of Image Optimization | B Line MarketingBenefits of Image Optimization | B Line Marketing
Benefits of Image Optimization | B Line Marketing
 
Nurul i
Nurul iNurul i
Nurul i
 
Final AMD poster 1
Final AMD poster 1Final AMD poster 1
Final AMD poster 1
 
Présentation - AtHome
Présentation - AtHomePrésentation - AtHome
Présentation - AtHome
 
HAPPYWEEK 202 - 2017.01.16.
HAPPYWEEK 202 - 2017.01.16.HAPPYWEEK 202 - 2017.01.16.
HAPPYWEEK 202 - 2017.01.16.
 
Expertise: Retail | Kids | Toys | Pets
Expertise: Retail | Kids | Toys | PetsExpertise: Retail | Kids | Toys | Pets
Expertise: Retail | Kids | Toys | Pets
 
Oil & Gas Sectoral Report - October 2016
Oil & Gas Sectoral Report - October 2016Oil & Gas Sectoral Report - October 2016
Oil & Gas Sectoral Report - October 2016
 
L2 Intelligence Report: E-Commerce Agility
L2 Intelligence Report: E-Commerce AgilityL2 Intelligence Report: E-Commerce Agility
L2 Intelligence Report: E-Commerce Agility
 
HAPPYWEEK 203 - 2017.01.23.
HAPPYWEEK 203 - 2017.01.23.HAPPYWEEK 203 - 2017.01.23.
HAPPYWEEK 203 - 2017.01.23.
 
Roberto veiga unir complementos-t03 entregable stem 20160621
Roberto veiga   unir complementos-t03 entregable stem 20160621Roberto veiga   unir complementos-t03 entregable stem 20160621
Roberto veiga unir complementos-t03 entregable stem 20160621
 

Similar to Global action plan to combat antimicrobial resistance

Global action plan to combat antimicrobial resistance (AMR)
Global action plan to combat antimicrobial resistance (AMR)Global action plan to combat antimicrobial resistance (AMR)
Global action plan to combat antimicrobial resistance (AMR)WHO Regional Office for Europe
 
GHSA and Progress in Pakistan 2018.pdf
GHSA and Progress in Pakistan 2018.pdfGHSA and Progress in Pakistan 2018.pdf
GHSA and Progress in Pakistan 2018.pdfFarhadAli820363
 
Antimicrobial Resistance A One Health Challenge for Joint Action
Antimicrobial Resistance A One Health Challenge for Joint Action Antimicrobial Resistance A One Health Challenge for Joint Action
Antimicrobial Resistance A One Health Challenge for Joint Action Ekaterina Bessonova
 
Antimicrobial Resistance A One Health Challenge for Joint Action
Antimicrobial Resistance A One Health Challenge for Joint Action Antimicrobial Resistance A One Health Challenge for Joint Action
Antimicrobial Resistance A One Health Challenge for Joint Action SIANI
 
Antimicrobial Resistance: A One Health Challenge for Joint Action
Antimicrobial Resistance: A One Health Challenge for Joint ActionAntimicrobial Resistance: A One Health Challenge for Joint Action
Antimicrobial Resistance: A One Health Challenge for Joint ActionSIANI
 
Environmental safeguarding of global health initiatives
Environmental safeguarding of global health initiativesEnvironmental safeguarding of global health initiatives
Environmental safeguarding of global health initiativesUNDP Eurasia
 
UNDP Key Achievements in introducing Sustainable Procurement in the Health Se...
UNDP Key Achievements in introducing Sustainable Procurement in the Health Se...UNDP Key Achievements in introducing Sustainable Procurement in the Health Se...
UNDP Key Achievements in introducing Sustainable Procurement in the Health Se...UN SPHS
 
Global and National Action Plan on Anti-Microbial Resistance
Global and National Action Plan on Anti-Microbial ResistanceGlobal and National Action Plan on Anti-Microbial Resistance
Global and National Action Plan on Anti-Microbial ResistanceZaid Wani
 
Antibiotic Guardian Leeds Workshop 2016
Antibiotic Guardian Leeds Workshop 2016Antibiotic Guardian Leeds Workshop 2016
Antibiotic Guardian Leeds Workshop 20164 All of Us
 
National action plan on sustainable use of pesticides in lithuania (r.semaski...
National action plan on sustainable use of pesticides in lithuania (r.semaski...National action plan on sustainable use of pesticides in lithuania (r.semaski...
National action plan on sustainable use of pesticides in lithuania (r.semaski...cropprotection
 
Epidemic of cardiovascular risk; focus on policy recommendations for diabetes...
Epidemic of cardiovascular risk; focus on policy recommendations for diabetes...Epidemic of cardiovascular risk; focus on policy recommendations for diabetes...
Epidemic of cardiovascular risk; focus on policy recommendations for diabetes...Feisul Mustapha
 
The XII Healthy Hospitals Seminar (Seminário Hospitais Saudáveis - SHS 2019)
The XII Healthy Hospitals Seminar (Seminário  Hospitais Saudáveis - SHS 2019)The XII Healthy Hospitals Seminar (Seminário  Hospitais Saudáveis - SHS 2019)
The XII Healthy Hospitals Seminar (Seminário Hospitais Saudáveis - SHS 2019)UN SPHS
 

Similar to Global action plan to combat antimicrobial resistance (20)

WHO Global Action Plan. Charles Penn (WHO)
WHO Global Action Plan. Charles Penn (WHO)WHO Global Action Plan. Charles Penn (WHO)
WHO Global Action Plan. Charles Penn (WHO)
 
Global action plan to combat antimicrobial resistance (AMR)
Global action plan to combat antimicrobial resistance (AMR)Global action plan to combat antimicrobial resistance (AMR)
Global action plan to combat antimicrobial resistance (AMR)
 
Implementing resolution WHA67.6 on hepatitis
Implementing resolution WHA67.6 on hepatitis Implementing resolution WHA67.6 on hepatitis
Implementing resolution WHA67.6 on hepatitis
 
Antimicorbial resistance in the Eastern Mediterranean Region - English
Antimicorbial resistance in the Eastern Mediterranean Region - EnglishAntimicorbial resistance in the Eastern Mediterranean Region - English
Antimicorbial resistance in the Eastern Mediterranean Region - English
 
GHSA and Progress in Pakistan 2018.pdf
GHSA and Progress in Pakistan 2018.pdfGHSA and Progress in Pakistan 2018.pdf
GHSA and Progress in Pakistan 2018.pdf
 
Antimicrobial Resistance A One Health Challenge for Joint Action
Antimicrobial Resistance A One Health Challenge for Joint Action Antimicrobial Resistance A One Health Challenge for Joint Action
Antimicrobial Resistance A One Health Challenge for Joint Action
 
Antimicrobial Resistance A One Health Challenge for Joint Action
Antimicrobial Resistance A One Health Challenge for Joint Action Antimicrobial Resistance A One Health Challenge for Joint Action
Antimicrobial Resistance A One Health Challenge for Joint Action
 
Antimicrobial Resistance: A One Health Challenge for Joint Action
Antimicrobial Resistance: A One Health Challenge for Joint ActionAntimicrobial Resistance: A One Health Challenge for Joint Action
Antimicrobial Resistance: A One Health Challenge for Joint Action
 
The National Antibiotic Guidelines: Shepherding Clinicians towards Rational u...
The National Antibiotic Guidelines: Shepherding Clinicians towards Rational u...The National Antibiotic Guidelines: Shepherding Clinicians towards Rational u...
The National Antibiotic Guidelines: Shepherding Clinicians towards Rational u...
 
Environmental safeguarding of global health initiatives
Environmental safeguarding of global health initiativesEnvironmental safeguarding of global health initiatives
Environmental safeguarding of global health initiatives
 
UNDP Key Achievements in introducing Sustainable Procurement in the Health Se...
UNDP Key Achievements in introducing Sustainable Procurement in the Health Se...UNDP Key Achievements in introducing Sustainable Procurement in the Health Se...
UNDP Key Achievements in introducing Sustainable Procurement in the Health Se...
 
Global and National Action Plan on Anti-Microbial Resistance
Global and National Action Plan on Anti-Microbial ResistanceGlobal and National Action Plan on Anti-Microbial Resistance
Global and National Action Plan on Anti-Microbial Resistance
 
Dr Mark Schipp
Dr Mark SchippDr Mark Schipp
Dr Mark Schipp
 
WHO Guidelines on Core Components of Infection Prevention and Control (IPC) P...
WHO Guidelines on Core Components of Infection Prevention and Control (IPC) P...WHO Guidelines on Core Components of Infection Prevention and Control (IPC) P...
WHO Guidelines on Core Components of Infection Prevention and Control (IPC) P...
 
Antibiotic Guardian Leeds Workshop 2016
Antibiotic Guardian Leeds Workshop 2016Antibiotic Guardian Leeds Workshop 2016
Antibiotic Guardian Leeds Workshop 2016
 
National action plan on sustainable use of pesticides in lithuania (r.semaski...
National action plan on sustainable use of pesticides in lithuania (r.semaski...National action plan on sustainable use of pesticides in lithuania (r.semaski...
National action plan on sustainable use of pesticides in lithuania (r.semaski...
 
Epidemic of cardiovascular risk; focus on policy recommendations for diabetes...
Epidemic of cardiovascular risk; focus on policy recommendations for diabetes...Epidemic of cardiovascular risk; focus on policy recommendations for diabetes...
Epidemic of cardiovascular risk; focus on policy recommendations for diabetes...
 
The XII Healthy Hospitals Seminar (Seminário Hospitais Saudáveis - SHS 2019)
The XII Healthy Hospitals Seminar (Seminário  Hospitais Saudáveis - SHS 2019)The XII Healthy Hospitals Seminar (Seminário  Hospitais Saudáveis - SHS 2019)
The XII Healthy Hospitals Seminar (Seminário Hospitais Saudáveis - SHS 2019)
 
food safety.pptx
food safety.pptxfood safety.pptx
food safety.pptx
 
Ev 20141028 c04_en
Ev 20141028 c04_enEv 20141028 c04_en
Ev 20141028 c04_en
 

More from WHO Regional Office for Europe

EpiData 4/2022, Ежемесячная сводка эпидемиологических данных об отдельных упр...
EpiData 4/2022, Ежемесячная сводка эпидемиологических данных об отдельных упр...EpiData 4/2022, Ежемесячная сводка эпидемиологических данных об отдельных упр...
EpiData 4/2022, Ежемесячная сводка эпидемиологических данных об отдельных упр...WHO Regional Office for Europe
 
Measles and rubella monthly update—WHO European Region, 4/2022
Measles and rubella monthly update—WHO European Region, 4/2022Measles and rubella monthly update—WHO European Region, 4/2022
Measles and rubella monthly update—WHO European Region, 4/2022WHO Regional Office for Europe
 
Ежемесячная сводка эпидемиологических данных ВОЗ, 3/2022
Ежемесячная сводка эпидемиологических данных ВОЗ, 3/2022Ежемесячная сводка эпидемиологических данных ВОЗ, 3/2022
Ежемесячная сводка эпидемиологических данных ВОЗ, 3/2022WHO Regional Office for Europe
 
EpiData 3/2022, for the period March 2021—February 2022 (data as of 30 March...
EpiData 3/2022,  for the period March 2021—February 2022 (data as of 30 March...EpiData 3/2022,  for the period March 2021—February 2022 (data as of 30 March...
EpiData 3/2022, for the period March 2021—February 2022 (data as of 30 March...WHO Regional Office for Europe
 
Ежемесячные обновленные данные по кори и краснухе—Европейского региона ВОЗ 2/...
Ежемесячные обновленные данные по кори и краснухе—Европейского региона ВОЗ 2/...Ежемесячные обновленные данные по кори и краснухе—Европейского региона ВОЗ 2/...
Ежемесячные обновленные данные по кори и краснухе—Европейского региона ВОЗ 2/...WHO Regional Office for Europe
 
Measles and rubella monthly update—WHO European Region 2/2022
Measles and rubella monthly update—WHO European Region 2/2022Measles and rubella monthly update—WHO European Region 2/2022
Measles and rubella monthly update—WHO European Region 2/2022WHO Regional Office for Europe
 
Ежемесячная сводка Epidata Russian 11/2021
Ежемесячная сводка Epidata Russian 11/2021Ежемесячная сводка Epidata Russian 11/2021
Ежемесячная сводка Epidata Russian 11/2021WHO Regional Office for Europe
 
EpiData 9/2021 for the period September 2020—August 2021 (data as of 30 Septe...
EpiData 9/2021 for the period September 2020—August 2021 (data as of 30 Septe...EpiData 9/2021 for the period September 2020—August 2021 (data as of 30 Septe...
EpiData 9/2021 for the period September 2020—August 2021 (data as of 30 Septe...WHO Regional Office for Europe
 
Ежемесячная сводка таблица 8/2021.
Ежемесячная сводка таблица 8/2021.Ежемесячная сводка таблица 8/2021.
Ежемесячная сводка таблица 8/2021.WHO Regional Office for Europe
 
EpiData 7/2021 Reported measles cases for the period July 2020—June 2021 (dat...
EpiData 7/2021 Reported measles cases for the period July 2020—June 2021 (dat...EpiData 7/2021 Reported measles cases for the period July 2020—June 2021 (dat...
EpiData 7/2021 Reported measles cases for the period July 2020—June 2021 (dat...WHO Regional Office for Europe
 

More from WHO Regional Office for Europe (20)

EpiData 4/2022, Ежемесячная сводка эпидемиологических данных об отдельных упр...
EpiData 4/2022, Ежемесячная сводка эпидемиологических данных об отдельных упр...EpiData 4/2022, Ежемесячная сводка эпидемиологических данных об отдельных упр...
EpiData 4/2022, Ежемесячная сводка эпидемиологических данных об отдельных упр...
 
Measles and rubella monthly update—WHO European Region, 4/2022
Measles and rubella monthly update—WHO European Region, 4/2022Measles and rubella monthly update—WHO European Region, 4/2022
Measles and rubella monthly update—WHO European Region, 4/2022
 
Ежемесячная сводка эпидемиологических данных ВОЗ, 3/2022
Ежемесячная сводка эпидемиологических данных ВОЗ, 3/2022Ежемесячная сводка эпидемиологических данных ВОЗ, 3/2022
Ежемесячная сводка эпидемиологических данных ВОЗ, 3/2022
 
EpiData 3/2022, for the period March 2021—February 2022 (data as of 30 March...
EpiData 3/2022,  for the period March 2021—February 2022 (data as of 30 March...EpiData 3/2022,  for the period March 2021—February 2022 (data as of 30 March...
EpiData 3/2022, for the period March 2021—February 2022 (data as of 30 March...
 
Epidata 3/2022
Epidata  3/2022Epidata  3/2022
Epidata 3/2022
 
Ежемесячные обновленные данные по кори и краснухе—Европейского региона ВОЗ 2/...
Ежемесячные обновленные данные по кори и краснухе—Европейского региона ВОЗ 2/...Ежемесячные обновленные данные по кори и краснухе—Европейского региона ВОЗ 2/...
Ежемесячные обновленные данные по кори и краснухе—Европейского региона ВОЗ 2/...
 
Measles and rubella monthly update—WHO European Region 2/2022
Measles and rubella monthly update—WHO European Region 2/2022Measles and rubella monthly update—WHO European Region 2/2022
Measles and rubella monthly update—WHO European Region 2/2022
 
EpiData 1/2022 Russian
EpiData 1/2022 RussianEpiData 1/2022 Russian
EpiData 1/2022 Russian
 
EpiData 1/2022
EpiData 1/2022EpiData 1/2022
EpiData 1/2022
 
EpiData 12/2021 Russian
EpiData 12/2021 RussianEpiData 12/2021 Russian
EpiData 12/2021 Russian
 
Epidata 12/2021
Epidata 12/2021Epidata 12/2021
Epidata 12/2021
 
Ежемесячная сводка Epidata Russian 11/2021
Ежемесячная сводка Epidata Russian 11/2021Ежемесячная сводка Epidata Russian 11/2021
Ежемесячная сводка Epidata Russian 11/2021
 
Epidata 11/2021
Epidata 11/2021 Epidata 11/2021
Epidata 11/2021
 
EpiData 10/2021
EpiData 10/2021EpiData 10/2021
EpiData 10/2021
 
EpiData 9/2021 for the period September 2020—August 2021 (data as of 30 Septe...
EpiData 9/2021 for the period September 2020—August 2021 (data as of 30 Septe...EpiData 9/2021 for the period September 2020—August 2021 (data as of 30 Septe...
EpiData 9/2021 for the period September 2020—August 2021 (data as of 30 Septe...
 
Ежемесячная сводка таблица 8/2021.
Ежемесячная сводка таблица 8/2021.Ежемесячная сводка таблица 8/2021.
Ежемесячная сводка таблица 8/2021.
 
EpiData 8/2021
EpiData 8/2021EpiData 8/2021
EpiData 8/2021
 
EpiData 7/2021 Reported measles cases for the period July 2020—June 2021 (dat...
EpiData 7/2021 Reported measles cases for the period July 2020—June 2021 (dat...EpiData 7/2021 Reported measles cases for the period July 2020—June 2021 (dat...
EpiData 7/2021 Reported measles cases for the period July 2020—June 2021 (dat...
 
EpiData 5/2021
EpiData 5/2021EpiData 5/2021
EpiData 5/2021
 
EpiData monthly 4/2021
EpiData monthly 4/2021EpiData monthly 4/2021
EpiData monthly 4/2021
 

Global action plan to combat antimicrobial resistance

  • 1. Global action plan to combat antimicrobial resistance Global action plan to combat 1 | antimicrobial resistance | 17 September 2014
  • 2. Antimicrobial resistance (AMR)  Increasingly serious global public health threat  Winning the battle in some areas – Reduced AMR in some countries – Attention on infection control, use of medicines – Supported by increasing engagement with agriculture – Some increase in investment  But losing the war – AMR everywhere and increasing – Major knowledge gaps – Fragmented response Global action plan to combat 2 | antimicrobial resistance | 17 September 2014
  • 3. World Health Assembly resolution on AMR  Resolution WHA67.25 requests the Director-General “to develop a draft global action plan to combat antimicrobial resistance ... to ensure that all countries ... have the capacity to combat antimicrobial resistance”. – Take account of existing action plans and all available evidence and best practice – Apply a multisectoral approach through consultation  Planned to be submitted to 2015 Health Assembly through the Executive Board (January 2015) Global action plan to combat 3 | antimicrobial resistance | 17 September 2014
  • 4. Draft global action plan  Includes: – context, including current progress – main concerns or priorities for action – guiding principles and values – key targets and quantifiable objectives – monitoring and reporting of progress – key stakeholders (roles and responsibilities) – support functions and mechanisms (including WHO role). Global action plan to combat 4 | antimicrobial resistance | 17 September 2014
  • 5. Draft global action plan  Based on 6 guiding principles – Whole-of-society engagement – Actions based on best available knowledge and evidence – Prevention first – Access, not excess – Sustainability – Incremental targets for implementation Global action plan to combat 5 | antimicrobial resistance | 17 September 2014
  • 6. Five strategic objectives  Improve awareness and understanding  Strengthen the knowledge and evidence base  Reduce the incidence of infection  Optimize the use of antimicrobial medicines  Develop the business case for sustainable investment Commitments to report on progress and monitor impact Global action plan to combat 6 | antimicrobial resistance | 17 September 2014
  • 7. Consultation and multisectoral engagement  Regional committee sessions  Consultation with Member States, 16 October 2014, Geneva  Consultations led by Member States – Netherlands, June 2014 – One Health – Brazil, October 2014 – research and knowledge gaps – Norway (7 sponsor countries), November 2014 – optimizing use – Sweden, December 2014 – establishing global surveillance for AMR Global action plan to combat 7 | antimicrobial resistance | 17 September 2014
  • 8. Consultation and multisectoral engagement  Meetings of WHO’s Strategic and Technical Advisory Group on Antimicrobial Resistance (STAG) – September 2013, April 2014, October 2014  Bilateral and multilateral engagement – World Bank, Food and Agriculture Organization of the United Nations (FAO), World Organisation for Animal Health (OIE) and others to address the economic impact  A web-based consultation for input in draft action plan – July–August 2014 – 2nd web call, January 2015 Global action plan to combat 8 | antimicrobial resistance | 17 September 2014

Editor's Notes

  1. 17 September, 2014
  2. 17 September, 2014
  3. WHO will lead the development of a draft global action plan that reflects the commitment, perspectives and roles of all relevant stakeholders, and in which everyone has clear and shared ownership and responsibilities.
  4. The action plan is based on six guiding principles: Whole of society engagement. Antimicrobial resistance will affect every individual, regardless of their health or economic circumstances, lifestyles or behaviours. It will also have an impact on many sectors beyond health including food security, agriculture and animal health, development including economic development. Everyone therefore needs to be engaged in the implementation of this action plan on a personal or professional basis. Actions need to be based on best available knowledge and evidence. With scarce resources and many competing health and economic priorities, is essential that the actions and investment needed to address antimicrobial resistance are supported wherever possible by clear and compelling evidence or rationale for their benefit and cost-effectiveness. Difficult or costly actions are also too easily avoided or challenged without such evidence. However, the need for action now is clear and must not be delayed because of gaps in scientific evidence or knowledge. Prevention first. Preventing infection (without use of antimicrobial medicines) has multiple benefits. Every infection prevented is one that does not need treatment whether appropriately or inappropriately, and is also not a source of further infections. Many interventions and practices for the prevention of infection are cost effective and can be implemented in all resource settings and sectors. Access not excess. The overall goal is to preserve our ability to treat serious infections. In some contexts preserving the effectiveness of antimicrobial medicines means using less. In other settings, poor access to affordable quality assured medicines is currently compromising health outcomes. Actions to address antimicrobial resistance need to take into account the need to maintain equitable access to and appropriate use of existing and new antimicrobial medicines. Sustainability. Addressing antimicrobial resistance will require long term change and investment, and new practices may need to be maintained indefinitely. Actions are more likely to be sustainable where they are integral to health systems or practices in other sectors, and where there is evidence of continuing health and economic benefit. Incremental targets for implementation. All countries and other stakeholders need to be able to demonstrate progress towards implementation of the global action plan, whatever their current status. A step-wise approach to targets and performance indicators for implementation of the plan, based on a series of “building-blocks” will allow for different priorities and capacities among Member States and other stakeholders.
  5. The Strategic and Technical Advisory Group (STAG) on antimicrobial resistance has been convened to advise the Director-General on the main areas of concern, priorities for action, and medium- to long-term objectives for inclusion in the draft global action plan. WHO will continue to work with its Strategic and Technical Advisory Group on Antimicrobial Resistance, to engage with a wide range of organizations and experts in order to set out the scientific and policy issues, develop proposals for targets and indicators, and review the draft action plan prior to its submission to the governing bodies in 2015. The next meeting is being planned for 16 to 17 October 2014, and a further meeting prior to the Health Assembly in 2015. http://www.who.int/drugresistance/stag/en/ June 2014: http://www.who.int/drugresistance/netherlands_meeting_june_2014/en/
  6. 17 September 2014